On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

A new study led by scientists from the University of Zurich and the University Hospital of Psychiatry Zurich has found a ...

A new study led by the University of Zurich has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the ...

A new study has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the disorder.

Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...

The retina, as part of the central nervous system, may reflect early signs of brain disorders like schizophrenia.

The retina is part of the central nervous system, and therefore a direct extension of the brain. This is why changes in the ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

What causes schizophrenia? This severe mental illness, which affects more than 20 million people worldwide and is ...

After a 17-year-old girl was diagnosed with a health condition known as 'popcorn lung' following a vaping habit, here are all the symptoms of the condition you can look out for. Brianne Cullen, from ...

The extended-release delivery coupled with the 351mg dose allows for single-dose initiation. Erzofri ® (paliperidone palmitate) extended-release injectable suspension is now available for the ...

Schizophrenia is a long-term mental health condition that causes one to experience distortions in reality. It may cause symptoms such as: delusions (beliefs that are contrary to facts or evidence ...